"The Theralase Laser is the most effective technology we have ever used. Our players now rely on Theralase to keep them healthy and playing at their peak".
George Poulis and
Dave Abraham
Toronto Blue Jays
Athletic Trainers
Investor Relations
Theralase Inc. is a subsidiary of Theralase Technologies Inc. (TLT – TSX.V)
Theralase Inc. Milestones
| 1995 | Canadian federal incorporation |
| 1998 | $250k equity financing (TLC-1000) |
| 2002 | $600k equity financing (FDA clinical study) |
| 2003 | $500k equity financing (RTO Theralase Technologies) |
| 2004 | ISO-13485 approval (Health Canada) |
| 2005 | FDA 510k approval (USA) |
| 2007E | CE approval (Europe) |
Share Information
| Stock Exchanges | TSX Venture Exchange OTC BB Nasdaq |
| Trading Symbols | TLT – (TSX Venture Exchange) TLTFF – (OTC BB Nasdaq) |
| Free Trading | 22,757,817 |
| Escrow | 10,328,908 |
| Total Issued & Outstanding | 33,236,725 |
SEDAR Filings
Stock Quote
- Stock quotes provided by the TSX Group.
- For a current Stock Quote, please Click Here